iSBTc 24th Annual Meeting

October 29 - 31, 2009                                                                                    
Gaylord National Hotel and Convention CenteriSBTc 2009 Final Program
National Harbor, MD - Washington, D.C.

A record setting number of attendees converged in Washington, D.C. for the very successful iSBTc 24th Annual Meeting October 29-31, 2009 at the Gaylord National Hotel.  Over 500 scientists, clinicians, students, fellows, researchers, and industry and regulatory representatives from 27 countries attended, shared cutting-edge science, and jointly celebrated the advancement and success of the immunotherapy/biological therapy field. There was much excitement among attendees centered on the high quality science, networking opportunities, and caliber of speakers and attendees present at the iSBTc 24th Annual Meeting.

 

Record Setting Year!

The iSBTc 24th Annual Meeting set several records including:

  • Program Attendance - over 500 attendees!
  • Countries Represented - people from 27 countries were in attendance.
  • Abstract Submissions - over 200 regular and late-breaking abstracts were submitted.
  • Young Investigator Award Candidates - over 100 abstracts submitted for consideration.

 Topics Presented / Discussed

Adoptive Transfer Monoclonal Antibodies / Combinations
Clinical Trials of New Agents Regulatory & Activated T Cell Subsets  
Cytokines / Immunotherapy Stem Cells / Circulating Tumor Cells
Enhancing Cancer Vaccines / Combinations Targeted Therapeutics & Biological Therapy  
Human Immunology Viral & Cellular Proteomic Targets  
Manipulation of the Tumor Microenvironment

 

Annual Meeting Organizers

Lieping Chen, MD, PhD
Johns Hopkins University School of Medicince
Giorgio Trinchieri, MD
National Cancer Institute                                        
Robert Ferris, MD, PhD
University of Pittsburgh Cancer Institute
Laurence Zitvogel, MD, PhD
Institute Gustave Roussy
Carl H. June, MD
University of Pennsylvania